C. Ola Landgren, MD (IMAGE)

University of Miami Miller School of Medicine

C. Ola Landgren, MD

Caption

“I hope this study highlights that AI can move beyond simply automating workflows and instead become a powerful tool for biologic discovery and clinical decision support,” said C. Ola Landgren, M.D., Ph.D., the study’s senior author and director of the Sylvester Myeloma Institute. “This may represent the beginning of a new era of AI-enabled digital pathology in myeloma.”

Credit

Sylvester Comprehensive Cancer Center

Usage Restrictions

Use with attribution

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.